Bank of Baroda surges on strong Q1FY19 results Bank of Baroda surges on strong Q1FY19 results Rohan Takalkar / Monday, July 30, 2018 0 1448 Article rating: 4.0 The net interest income for the quarter increased by 28 per cent yoy and 9.5 per cent qoq to Rs. 4,381 crore in Q1FY19 vs Rs. 3,405 crore in the same period the previous year. The interest income for the quarter rose by 10.3 per cent yoy to Rs. 11,639 crore in Q1FY19. Read more
Ten stocks close to their 52-week low Ten stocks close to their 52-week low Shital Jibhe / Monday, July 30, 2018 0 1555 Article rating: 5.0 Following stocks are close to their 52-week low as at 1.09 p.m. on July 30, 2018. Read more
Aurobindo Pharma receives USFDA Approval for Bivalirudin Injection Aurobindo Pharma receives USFDA Approval for Bivalirudin Injection Shohini Nath / Monday, July 30, 2018 0 1571 Article rating: 5.0 Aurobindo Pharma has received the final approval from the US Food and Drug Administration for Bivalirudin Injection indicated for the use as an anticoagulant in patients. The product will be launched in September 2018. With respect to the news, the shares of Aurobindo soared 2 per cent. Read more
Ten stocks close to their 52-week high Ten stocks close to their 52-week high Shital Jibhe / Monday, July 30, 2018 0 1127 Article rating: 5.0 The markets on July 30, 2018 opened gap up. BSE Sensex is trading at 37,407.49, up by 70.64 points and the Nifty is trading at 11,290.45, up by 12.10 points. Read more
Wockhardt sets-up facility in Middle East, surges by 3.5 per cent Wockhardt sets-up facility in Middle East, surges by 3.5 per cent Apurva Joshi / Monday, July 30, 2018 0 1247 Article rating: 5.0 Wockhardt Limited has set-up its first facility in the Middle East for manufacturing of NCEs (New Chemical Entities). It will cater to the global markets through its Dubai arm of its subsidiary Wockhardt Bio AG. Read more